BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  IDEAYA Biosciences Reports Positive Median Overall Survival Data from Phase 2 Trial of the Darovasertib and Crizotinib Combination in First-line Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress

  October 21, 2025

   · 

  6 min read
• Press Releases

  Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones

  October 21, 2025

   · 

  7 min read
• Press Releases

  Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025

  October 21, 2025

   · 

  6 min read
• Press Releases

  Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington’s Disease Treatment

  October 21, 2025

   · 

  2 min read
• Press Releases

  Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

  October 21, 2025

   · 

  7 min read
• Press Releases

  Danaher Reports Third Quarter 2025 Results

  October 21, 2025

   · 

  21 min read
• Press Releases

  Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral Drugs for Chronic Gout and Acute Gout Flares at ACR Convergence 2025

  October 21, 2025

   · 

  3 min read
• Press Releases

  Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar

  October 21, 2025

   · 

  2 min read
• Press Releases

  Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

  October 21, 2025

   · 

  3 min read
• Press Releases

  Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025

  October 21, 2025

   · 

  5 min read